APAC Digital Therapeutic Market

The Asia Pacific digital therapeutic market is anticipated to grow with an CAGR of 37.7% during the forecasted period 2016-2022. The rapid increase in life style oriented diseases, growing research and development funding by government and private players for the technological invention in digital therapeutic is driving the growth in #Asia #Pacific #digital #therapeutic #market. Moreover, the increasing occurrence of preventable chronic diseases and on the way to precautionary healthcare is fueling the growth in Asia Pacific digital therapeutic market. The growing prevalence of the life style oriented diseases is one of the key forces which is rising the growth in the Asia Pacific digital therapeutic market. The cardiac disease is the key life style oriented diseases which is impacting the growth of digital therapeutic market. CVD (cardiovascular diseases) are the leading cause for death in the China region. The rapid urbanization in the China region, hasty economic development, rapid change in the dietary habits and smoking habits are the key factors which is increasing the prevalence of the cardiac diseases in China. By the end of 2030, it is estimated that around 25 million will suffer from cardiovascular diseases out of which more than 8 million people is expected to die from cardiac diseases. Thus, In Asia Pacific Chinese people are on the great health risk basically risk of heart diseases. Moreover, the lack of awareness and privacy and security related concern for patient data are few factors which are restraining the growth of the Asia Pacific digital therapeutic market. The security and privacy concerns which are basically related to patient data is one of the key factor which is hindering the growth of the Asia Pacific digital therapeutic market. Although, the Asia Pacific market is having gigantic opportunity for digital therapeutic market. The increasing patient pool in the emerging country and rising elderly population are the key opportunistic factor which are expected to create huge opportunity for the Asia Pacific digital therapeutic market. Moreover, the rise in the number of unexplored therapeutic application is influencing growth opportunity in the Asia Pacific digital therapeutic market.

 The global digital therapeutic market is growing with a CAGR of 34.8% during forecast period. The growth in the global digital therapeutic market is mainly driven by the rising prevalence of life style oriented diseases across the globe. The global digital therapeutic market is valued at $100 million in 2016 which is expected to reach to $660 million by the end of 2022. As compared to global market the Asia Pacific market is growing with a high CAGR of 37.7% during forecast period. Asia Pacific region have huge growth potential due to rising patient pool in the Asia Pacific region.

 The Asia Pacific digital therapeutic market is segmented on the basis of application and geography. The application segment is broadly segmented into treatment / care related application and preventive applications. The treatment related application is further sub divided into Central Nervous System (CNS) Disorders, Medication Adherence, Chronic Respiratory Diseases (CRD), Diabetes, Cardiovascular Diseases, Smoking Cessation and Musculoskeletal Disorders. The preventive application is sub divided into prediabetes and obesity. The preventive application is the fastest growing segment in the application segment market. The growth in the preventive application segment is mainly driven by the increasing prevalence of the preventive chronic diseases.

 Asia Pacific digital therapeutic market is dominated by the presence of some key players such as Doximity, Adheretech, Canary Health Inc., GE Healthcare, Evolent Health, Medtronic, Proteus Digital Health, Inc., Medisafe, Siemens, etc. Key strategies such as merger, acquisition, product launch are the strategic initiative taken by the key players to sustain in the dynamic market. In 2015, Medtronic has acquired Covidien plc. Covidien is an Irish company who is basically manufacturer and supplier of medical devices. These acquisitions allow Medtronic to expand the geographical presence and also helps to enhance the efficacy of the medical device.

The Asia Pacific digital therapeutic market geographically divided into India, China, Japan, Korea, and others. The China held the largest market share in the Asia Pacific region. Growth in China therapeutic market is mainly driven by the rising patient pool in China market. India is the fastest growing country in the Asia Pacific digital therapeutics market. The growth in India market is mainly attributed by the increasing prevalence of the life style oriented diseases. Moreover, the growing patient pool in India and rising medical tourism in India due to availability of low cost treatment facility in the India is rising the growth in the Asia Pacific region market.